$5.10
-0.25[-4.67%]
At close: Apr 23
$5.10
0[0.00%]
After Hours: 7:57PM EDT
Regencell Bioscience reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Regencell Bioscience using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|---|
06/13/2024 | PM | RGC | H1 | -$0.25 | — | — | — | $0.00 | — | — | — | Get Alert |
05/10/2024 | AM | RGC | FY | -$0.58 | — | — | — | $0.00 | — | — | — | Get Alert |
06/15/2023 | PM | RGC | H1 | -$0.29 | — | -$0.25 | — | $0.00 | — | $0.00 | — | Get Alert |
10/31/2022 | PM | RGC | FY | -$0.13 | — | -$0.58 | — | $0.00 | — | $0.00 | — | Get Alert |
Regencell Bioscience (RGC) is scheduled to report earnings on June 13, 2024. The last reported earnings were for reported on June 15, 2023 for H1.
The Actual EPS was $-0.25, which missed the estimate of $0.00.
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.